Thomas I‐Sheng Hwang

1.1k total citations
50 papers, 839 citations indexed

About

Thomas I‐Sheng Hwang is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Thomas I‐Sheng Hwang has authored 50 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Surgery and 12 papers in Epidemiology. Recurrent topics in Thomas I‐Sheng Hwang's work include Autophagy in Disease and Therapy (12 papers), MicroRNA in disease regulation (9 papers) and Genomics, phytochemicals, and oxidative stress (8 papers). Thomas I‐Sheng Hwang is often cited by papers focused on Autophagy in Disease and Therapy (12 papers), MicroRNA in disease regulation (9 papers) and Genomics, phytochemicals, and oxidative stress (8 papers). Thomas I‐Sheng Hwang collaborates with scholars based in Taiwan, United States and China. Thomas I‐Sheng Hwang's co-authors include Kuang‐Yu Chou, Te‐Fu Tsai, Ji‐Fan Lin, Hung‐En Chen, Yi‐Chia Lin, Po‐Chun Chen, Chi‐Rei Yang, Yi‐Hsuan Lin, Tom F. Lue and Stefan C. Mueller and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and The Journal of Urology.

In The Last Decade

Thomas I‐Sheng Hwang

48 papers receiving 824 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas I‐Sheng Hwang Taiwan 17 434 221 219 120 106 50 839
Te‐Fu Tsai Taiwan 19 546 1.3× 289 1.3× 264 1.2× 75 0.6× 49 0.5× 45 895
Elizabeth M. Masko United States 14 244 0.6× 87 0.4× 386 1.8× 111 0.9× 25 0.2× 17 979
Juan Jin China 15 367 0.8× 150 0.7× 140 0.6× 132 1.1× 16 0.2× 56 808
Cuicui Liu China 16 244 0.6× 103 0.5× 68 0.3× 38 0.3× 82 0.8× 57 762
Xuan Zheng China 16 153 0.4× 70 0.3× 45 0.2× 90 0.8× 36 0.3× 49 766
Peter M. Scarbrough United States 10 401 0.9× 42 0.2× 248 1.1× 41 0.3× 33 0.3× 12 848
Po‐Yuan Chang Taiwan 21 329 0.8× 188 0.9× 84 0.4× 284 2.4× 17 0.2× 43 1.0k
Zhi-Jiang Zhang China 15 584 1.3× 148 0.7× 180 0.8× 170 1.4× 56 0.5× 31 1.1k
Qi Hou China 14 235 0.5× 54 0.2× 84 0.4× 55 0.5× 16 0.2× 50 688

Countries citing papers authored by Thomas I‐Sheng Hwang

Since Specialization
Citations

This map shows the geographic impact of Thomas I‐Sheng Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas I‐Sheng Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas I‐Sheng Hwang more than expected).

Fields of papers citing papers by Thomas I‐Sheng Hwang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas I‐Sheng Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas I‐Sheng Hwang. The network helps show where Thomas I‐Sheng Hwang may publish in the future.

Co-authorship network of co-authors of Thomas I‐Sheng Hwang

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas I‐Sheng Hwang. A scholar is included among the top collaborators of Thomas I‐Sheng Hwang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas I‐Sheng Hwang. Thomas I‐Sheng Hwang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yu, An‐Chen Chang, Chih‐Hsin Tang, & Thomas I‐Sheng Hwang. (2025). Abstract 3439: Study on the mechanism of sesamin inhibiting the malignant metastasis of prostate cancer. Cancer Research. 85(8_Supplement_1). 3439–3439. 1 indexed citations
2.
Hwang, Thomas I‐Sheng & An‐Chen Chang. (2025). Tumor suppressor MiRNAs in bladder tumors: From preclinical research to therapeutic applications. Urological Science. 36(2). 54–60.
3.
Chang, An‐Chen, et al.. (2023). Hyperthermia Improves Doxorubicin-Based Chemotherapy by Activating Mitochondrial Apoptosis in Bladder Cancer. Urological Science. 34(2). 64–69. 1 indexed citations
4.
Chen, Yù, Hong‐Chiang Chang, William J. Huang, et al.. (2023). Consensus of Experts on the Treatment of Sexual Dysfunction after Surgery for Prostate Cancer in Taiwan. Journal of Clinical Medicine. 12(3). 740–740. 5 indexed citations
5.
Chou, Kuang‐Yu, An‐Chen Chang, Te‐Fu Tsai, et al.. (2021). Thrombospondin‐4 promotes bladder cancer cell migration and invasion via MMP2 production. Journal of Cellular and Molecular Medicine. 25(13). 6046–6055. 18 indexed citations
6.
Tsai, Te‐Fu, Po‐Chun Chen, Yi‐Chia Lin, et al.. (2020). <p>Miconazole Contributes to NRF2 Activation by Noncanonical P62-KEAP1 Pathway in Bladder Cancer Cells</p>. Drug Design Development and Therapy. Volume 14. 1209–1218. 25 indexed citations
7.
Lin, Ji‐Fan, Te‐Fu Tsai, Yi‐Chia Lin, et al.. (2019). Benzyl isothiocyanate suppresses IGF1R, FGFR3 and mTOR expression by upregulation of miR-99a-5p in human bladder cancer cells. International Journal of Oncology. 54(6). 2106–2116. 18 indexed citations
8.
Lin, Ji‐Fan, Po‐Chun Chen, & Thomas I‐Sheng Hwang. (2019). Autophagy Modulation by Dysregulated Micrornas in Human Bladder Cancer. SHILAP Revista de lepidopterología. 30(2). 46–52. 7 indexed citations
9.
Lin, Yi‐Chia, Ji‐Fan Lin, Te‐Fu Tsai, et al.. (2017). Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis. The Kaohsiung Journal of Medical Sciences. 33(5). 215–223. 92 indexed citations
10.
Lin, Ji‐Fan, Yi‐Chia Lin, Te‐Fu Tsai, et al.. (2016). Autophagy inhibition enhances RAD001-induced cytotoxicity in human bladder cancer cells. Drug Design Development and Therapy. 10. 1501–1501. 24 indexed citations
11.
Tsai, Te‐Fu, Ji‐Fan Lin, Hung‐En Chen, et al.. (2016). Benzyl isothiocyanate up-regulates MIR-99A-5P and induces autophagy by suppressing MTOR expression in human bladder cancer cells. Urological Science. 27(2). S44–S44. 1 indexed citations
12.
Lin, Yi‐Chia, Ji‐Fan Lin, Te‐Fu Tsai, et al.. (2016). Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells. Asian Journal of Surgery. 40(5). 396–406. 73 indexed citations
13.
Chou, Kuang‐Yu, Ji‐Fan Lin, Te‐Fu Tsai, et al.. (2016). Forced expression of MIR-30A-5P sensitizes bladder cancer cells to cisplatin via targeting ATG5 and Beclin-1. Urological Science. 27(2). S3–S4. 1 indexed citations
14.
Lin, Ji‐Fan, Te‐Fu Tsai, Yi‐Hsuan Lin, et al.. (2012). Benzyl isothiocyanate induces protective autophagy in human prostate cancer cells via inhibition of mTOR signaling. Carcinogenesis. 34(2). 406–414. 68 indexed citations
15.
Hwang, Thomas I‐Sheng, et al.. (2011). Extramammary Paget’s disease of the scrotum. Journal of the Chinese Medical Association. 74(7). 325–328. 9 indexed citations
16.
Hwang, Thomas I‐Sheng, et al.. (2002). Spontaneous Renal Hemorrhage：An Unusual Presentation of Renal Cell Carcinoma. 13(2). 72–75.
17.
Lin, Yung‐Wei & Thomas I‐Sheng Hwang. (2001). Leiomyoma of Urinary Bladder：A Case Report and Literature Review. 12(2). 96–98. 2 indexed citations
18.
Hwang, Thomas I‐Sheng, et al.. (2000). Hemangioma of the Kidney：A Case Report and Review of the Literature. 11(2). 78–81. 1 indexed citations
19.
20.
Hwang, Thomas I‐Sheng, et al.. (1989). Impotence Evaluated by the Use of Prostaglandin E1. The Journal of Urology. 141(6). 1357–1359. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Te‐Fu Tsai Breakdown of academic impact, for papers by Elizabeth M. Masko Breakdown of academic impact, for papers by Juan Jin Breakdown of academic impact, for papers by Cuicui Liu Breakdown of academic impact, for papers by Xuan Zheng Breakdown of academic impact, for papers by Peter M. Scarbrough Breakdown of academic impact, for papers by Po‐Yuan Chang Breakdown of academic impact, for papers by Zhi-Jiang Zhang Breakdown of academic impact, for papers by Qi Hou
Rankless by CCL
2026